Skip to main content
Grifols S.A. logo

Grifols S.A. — Investor Relations & Filings

Ticker · GRF ISIN · ES0171996087 LEI · 959800HSSNXWRKBK4N60 MC Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2025-03-31 Delisting Announcement
Country ES Spain
Listing MC GRF

About Grifols S.A.

https://www.grifols.com/en/home

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Recent filings

Filing Released Lang Actions
El Consejo de Administración ha aprobado por unanimidad que su filial Grifols Biotest Holdings GmbH presente una oferta pública de compra para la exclusión de cotización (delisting offer) a los acc...
Delisting Announcement Classification · 99% confidence The document is a formal communication from Grifols, S.A. titled "INFORMACIÓN PRIVILEGIADA" (Privileged Information). The core content announces that a subsidiary intends to launch a public tender offer (OPC) to acquire all shares of Biotest AG with the explicit goal of delisting Biotest from the stock exchange. This action falls under corporate restructuring, mergers, or takeover activities. Reviewing the definitions, the category 'M&A Activity (Code: TAR)' is described as 'Announcements and documents related to merger proposals or takeover bids.' The announcement of a public tender offer for delisting directly aligns with a takeover bid scenario. Although it mentions a future 'Documento de Oferta' which will be subject to regulatory approval (BaFin), the current document is the initial announcement of the intent to execute the takeover/delisting, making TAR the most appropriate classification over a general Regulatory Filing (RNS). The document length is short (2060 chars), but it is not merely announcing the publication of another report; it is the primary announcement of the corporate action itself.
2025-03-31 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Volume, Price, Date) conducted by a Director ('Consejero Dominical') of the issuer (GRIFOLS, S.A.). This directly corresponds to the definition of Director's Dealing (insider trades). The filing type code for Director's Dealing is DIRS.
2025-03-14 Spanish
FORM 6-K
Regulatory Filings
2025-03-10 English
Grifols desea informar sobre cierta información publicada en un medio de comunicación en fecha 8 de marzo de 2025.
Legal Proceedings Report Classification · 99% confidence The document is a formal communication from Grifols, S.A. titled 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information), issued in compliance with Spanish securities law (Ley 6/2023, artículo 227). The content directly addresses and refutes specific claims made in a media report regarding an ongoing administrative sanctioning procedure initiated by the CNMV (Spanish National Securities Market Commission) concerning alleged inaccuracies in financial reports from 2021 to 2023. This type of communication, which provides an official company response to market rumors or regulatory actions concerning legal or financial integrity, fits best under the category of general regulatory announcements or legal updates. Since it specifically discusses a regulatory proceeding and refutes allegations related to financial reporting integrity, it is a significant regulatory disclosure. Given the options, 'Legal Proceedings Report' (LTR) is highly relevant due to the mention of the sanctioning procedure, but 'Regulatory Filings' (RNS) serves as the best general category for mandatory, non-standard disclosures responding to market events or regulatory scrutiny that don't fit a more specific financial report type (like 10-K or ER). However, because the core subject is a dispute/action with a regulator (CNMV) regarding past financial reporting, and it is a formal communication of 'Other Relevant Information' responding to a legal/regulatory matter, LTR is a strong candidate. Given the context of refuting claims about financial statements and an ongoing administrative procedure, LTR (Legal Proceedings Report) is the most precise fit for this specific type of regulatory defense/clarification, although RNS is a possible fallback. I will classify it as LTR due to the explicit discussion of the sanctioning procedure and the legal defense against claims of 'dolo' (intent). The document length (3307 chars) is substantial enough to be the primary communication, not just an announcement of a report.
2025-03-10 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Compra/Buy) conducted by a Director (Raimon Grifols Roura, Vicepresidente - Consejero Dominical) in the company's shares. This directly corresponds to the definition of Director's Dealing (insider trades). The filing type code for Director's Dealing is DIRS.
2025-03-05 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Compra/Buy) made by a director (Raimon Grifols Roura, Vicepresidente) of the issuer (GRIFOLS, S.A.). This directly corresponds to the definition of Director's Dealing (insider trades). The available codes are: - DIRS: Director's Dealing (Report of personal share transactions by company directors and executives (insider trades)). - DEF 14A: Remuneration Information (Compensation). Since the content is a report of personal share transactions by a director, the correct classification is DIRS.
2025-02-28 Spanish

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.